Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial.
Schultz K, Jelusic D, Wittmann M, Krämer B, Huber V, Fuchs S, Lehbert N, Wingart S, Stojanovic D, Göhl O, Alma HJ, de Jong C, van der Molen T, Faller H, Schuler M. Schultz K, et al. Among authors: kramer b. Eur Respir J. 2018 Jan 25;51(1):1702000. doi: 10.1183/13993003.02000-2017. Print 2018 Jan. Eur Respir J. 2018. PMID: 29371382 Free article. Clinical Trial.
Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison.
Kornmann O, Dahl R, Centanni S, Dogra A, Owen R, Lassen C, Kramer B; INLIGHT-2 (Indacaterol Efficacy Evaluation Using 150-µg Doses with COPD Patients) study investigators. Kornmann O, et al. Among authors: kramer b. Eur Respir J. 2011 Feb;37(2):273-9. doi: 10.1183/09031936.00045810. Epub 2010 Aug 6. Eur Respir J. 2011. PMID: 20693243 Free article. Clinical Trial.
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
Buhl R, Dunn LJ, Disdier C, Lassen C, Amos C, Henley M, Kramer B; INTENSITY study investigators. Buhl R, et al. Among authors: kramer b. Eur Respir J. 2011 Oct;38(4):797-803. doi: 10.1183/09031936.00191810. Epub 2011 May 26. Eur Respir J. 2011. PMID: 21622587 Free article. Clinical Trial.
Effect of indacaterol on exercise endurance and lung hyperinflation in COPD.
O'Donnell DE, Casaburi R, Vincken W, Puente-Maestu L, Swales J, Lawrence D, Kramer B; INABLE 1 study group. O'Donnell DE, et al. Among authors: kramer b. Respir Med. 2011 Jul;105(7):1030-6. doi: 10.1016/j.rmed.2011.03.014. Epub 2011 Apr 16. Respir Med. 2011. PMID: 21498063 Free article. Clinical Trial.
Indacaterol once-daily is equally effective dosed in the evening or morning in COPD.
Magnussen H, Verkindre C, Jack D, Jadayel D, Henley M, Woessner R, Higgins M, Kramer B; INPUT study investigators. Magnussen H, et al. Among authors: kramer b. Respir Med. 2010 Dec;104(12):1869-76. doi: 10.1016/j.rmed.2010.08.010. Epub 2010 Sep 20. Respir Med. 2010. PMID: 20850959 Free article. Clinical Trial.
Efficacy of indacaterol in the treatment of patients with COPD.
Jones PW, Barnes N, Vogelmeier C, Lawrence D, Kramer B. Jones PW, et al. Among authors: kramer b. Prim Care Respir J. 2011 Dec;20(4):380-8. doi: 10.4104/pcrj.2011.00066. Prim Care Respir J. 2011. PMID: 21785813 Free PMC article. Review.
Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison.
Mahler DA, D'Urzo A, Bateman ED, Ozkan SA, White T, Peckitt C, Lassen C, Kramer B; INTRUST-1 and INTRUST-2 study investigators. Mahler DA, et al. Among authors: kramer b. Thorax. 2012 Sep;67(9):781-8. doi: 10.1136/thoraxjnl-2011-201140. Epub 2012 Apr 27. Thorax. 2012. PMID: 22544891 Clinical Trial.
2,194 results